Advocacy intelligence hub — real-time data for patient organizations
NORTHERA: FDA approved
Treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Myobloc
Soltice Neurosciences, LLC
Myobloc
(Botulinum toxin type B)Orphan drugstandardSoltice Neurosciences, LLC
Acetylcholine Release Inhibitor [EPC]
12.1 Mechanism of Action MYOBLOC blocks cholinergic transmission at the neuromuscular and salivary neuroglandular junction by inhibiting the release o...